Systemic and intravesical adoptive cell therapy of tumor-reactive T cells can decrease bladder tumor growth in vivo

BACKGROUND: The therapeutic armamentarium of bladder cancer has been recently enriched with the introduction of new therapies including immune checkpoint inhibitors, receptor tyrosine kinase inhibitors and antibody drug conjugates, however treatment responses and duration of responses are still less...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Bunch, Brittany L, Morse, Jennifer, Asby, Sarah, Blauvelt, Jamie, Aydin, Ahmet M, Innamarato, Patrick, Hajiran, Ali, Beatty, Matthew, Poch, Michael, Pilon-Thomas, Shari
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Immune Cell Therapies and Immune Cell Engineering
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7733200/
https://ncbi.nlm.nih.gov/pubmed/33303579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados